FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131388913> ?p ?o ?g. }

• W2131388913 endingPage "1007" @default.
• W2131388913 startingPage "1007" @default.
• W2131388913 abstract "Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular diseases. It is unclear, however, how long the increased risk persists and what the risk factors are for various cardiovascular diseases.To examine relative and absolute excess risk up to 40 years since HL treatment compared with cardiovascular disease incidence in the general population and to study treatment-related risk factors for different cardiovascular diseases.This retrospective cohort study included 2524 Dutch patients diagnosed as having HL at younger than 51 years (median age, 27.3 years) who had been treated from January 1, 1965, through December 31, 1995, and had survived for 5 years since their diagnosis.Treatment for HL, including prescribed mediastinal radiotherapy dose and anthracycline dose.Data were collected from medical records and general practitioners. Cardiovascular events, including coronary heart disease (CHD), valvular heart disease (VHD), and cardiomyopathy and congestive heart failure (HF), were graded according to the Common Terminology Criteria for Adverse Events, version 4.0.After a median follow-up of 20 years, we identified 1713 cardiovascular events in 797 patients. After 35 years or more, patients still had a 4- to 6-fold increased standardized incidence ratio of CHD or HF compared with the general population, corresponding to 857 excess events per 10,000 person-years. Highest relative risks were seen in patients treated before 25 years of age, but substantial absolute excess risks were also observed for patients treated at older ages. Within the cohort, the 40-year cumulative incidence of cardiovascular diseases was 50% (95% CI, 47%-52%). Fifty-one percent of patients with a cardiovascular disease developed multiple events. For patients treated before 25 years of age, cumulative incidences at 60 years or older were 20%, 31%, and 11% for CHD, VHD, and HF as first events, respectively. Mediastinal radiotherapy increased the risks of CHD (hazard ratio [HR], 2.7; 95% CI, 2.0-3.7), VHD (HR, 6.6; 95% CI, 4.0-10.8), and HF (HR, 2.7; 95% CI, 1.6-4.8), and anthracycline-containing chemotherapy increased the risks of VHD (HR, 1.5; 95% CI, 1.1-2.1) and HF (HR, 3.0; 95% CI, 1.9-4.7) as first events compared with patients not treated with mediastinal radiotherapy or anthracyclines, respectively. Joint effects of mediastinal radiotherapy, anthracyclines, and smoking appeared to be additive.Throughout their lives, HL survivors treated at adolescence or adulthood are at high risk for various cardiovascular diseases. Physicians and patients should be aware of this persistently increased risk." @default.
• W2131388913 created "2016-06-24" @default.
• W2131388913 creator A5005494079 @default.
• W2131388913 creator A5006805405 @default.
• W2131388913 creator A5012843588 @default.
• W2131388913 creator A5026185552 @default.
• W2131388913 creator A5028653037 @default.
• W2131388913 creator A5030601121 @default.
• W2131388913 creator A5036769821 @default.
• W2131388913 creator A5045222747 @default.
• W2131388913 creator A5052316741 @default.
• W2131388913 date "2015-06-01" @default.
• W2131388913 modified "2023-10-17" @default.
• W2131388913 title "Cardiovascular Disease After Hodgkin Lymphoma Treatment" @default.
• W2131388913 cites W1536128075 @default.
• W2131388913 cites W1589782664 @default.
• W2131388913 cites W1824227359 @default.
• W2131388913 cites W1833833181 @default.
• W2131388913 cites W1894979576 @default.
• W2131388913 cites W1964223445 @default.
• W2131388913 cites W1973617793 @default.
• W2131388913 cites W1976347407 @default.
• W2131388913 cites W1995679745 @default.
• W2131388913 cites W1996757133 @default.
• W2131388913 cites W2003897619 @default.
• W2131388913 cites W2022872482 @default.
• W2131388913 cites W2024136031 @default.
• W2131388913 cites W2030662776 @default.
• W2131388913 cites W2036791873 @default.
• W2131388913 cites W2043097489 @default.
• W2131388913 cites W2066617715 @default.
• W2131388913 cites W2078892942 @default.
• W2131388913 cites W2085143233 @default.
• W2131388913 cites W2093421164 @default.
• W2131388913 cites W2105436256 @default.
• W2131388913 cites W2108061720 @default.
• W2131388913 cites W2112578407 @default.
• W2131388913 cites W2116610563 @default.
• W2131388913 cites W2119843363 @default.
• W2131388913 cites W2122704305 @default.
• W2131388913 cites W2125784459 @default.
• W2131388913 cites W2134931633 @default.
• W2131388913 cites W2136546051 @default.
• W2131388913 cites W2138964436 @default.
• W2131388913 cites W2147498149 @default.
• W2131388913 cites W2148209445 @default.
• W2131388913 cites W2150503557 @default.
• W2131388913 cites W2159552035 @default.
• W2131388913 cites W2162084836 @default.
• W2131388913 cites W2171187650 @default.
• W2131388913 cites W2217904341 @default.
• W2131388913 cites W2243890309 @default.
• W2131388913 cites W2248977291 @default.
• W2131388913 doi "https://doi.org/10.1001/jamainternmed.2015.1180" @default.
• W2131388913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25915855" @default.
• W2131388913 hasPublicationYear "2015" @default.
• W2131388913 type Work @default.
• W2131388913 sameAs 2131388913 @default.
• W2131388913 citedByCount "351" @default.
• W2131388913 countsByYear W21313889132015 @default.
• W2131388913 countsByYear W21313889132016 @default.
• W2131388913 countsByYear W21313889132017 @default.
• W2131388913 countsByYear W21313889132018 @default.
• W2131388913 countsByYear W21313889132019 @default.
• W2131388913 countsByYear W21313889132020 @default.
• W2131388913 countsByYear W21313889132021 @default.
• W2131388913 countsByYear W21313889132022 @default.
• W2131388913 countsByYear W21313889132023 @default.
• W2131388913 crossrefType "journal-article" @default.
• W2131388913 hasAuthorship W2131388913A5005494079 @default.
• W2131388913 hasAuthorship W2131388913A5006805405 @default.
• W2131388913 hasAuthorship W2131388913A5012843588 @default.
• W2131388913 hasAuthorship W2131388913A5026185552 @default.
• W2131388913 hasAuthorship W2131388913A5028653037 @default.
• W2131388913 hasAuthorship W2131388913A5030601121 @default.
• W2131388913 hasAuthorship W2131388913A5036769821 @default.
• W2131388913 hasAuthorship W2131388913A5045222747 @default.
• W2131388913 hasAuthorship W2131388913A5052316741 @default.
• W2131388913 hasBestOaLocation W21313889131 @default.
• W2131388913 hasConcept C120195587 @default.
• W2131388913 hasConcept C120665830 @default.
• W2131388913 hasConcept C121332964 @default.
• W2131388913 hasConcept C126322002 @default.
• W2131388913 hasConcept C187212893 @default.
• W2131388913 hasConcept C197934379 @default.
• W2131388913 hasConcept C2777793932 @default.
• W2131388913 hasConcept C2778198053 @default.
• W2131388913 hasConcept C2779134260 @default.
• W2131388913 hasConcept C2908647359 @default.
• W2131388913 hasConcept C44249647 @default.
• W2131388913 hasConcept C61511704 @default.
• W2131388913 hasConcept C71924100 @default.
• W2131388913 hasConcept C72563966 @default.
• W2131388913 hasConcept C82789193 @default.
• W2131388913 hasConcept C88879693 @default.
• W2131388913 hasConcept C99454951 @default.
• W2131388913 hasConceptScore W2131388913C120195587 @default.
• W2131388913 hasConceptScore W2131388913C120665830 @default.

• next